The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
Open accessAbstract
Pharmacology over the past 100 years has had a rich tradition of scientists with the ability to form qualitative or semi‐quantitative relations between molecular structure and activity in cerebro. To test these hypotheses they have consistently used traditional pharmacology tools such as in vivo and in vitro models. Increasingly over the last decade however we have seen that computational (in silico) methods have been developed and applied to pharmacology hypothesis development and testing. These in silico methods include databases, quantitative structure‐activity relationships, pharmacophores, homology models and other molecular modeling approaches, machine learning, data mining, network analysis tools and data analysis tools that use a computer. In silico methods are primarily used alongside the generation of in vitro data both to create the model and to test it. Such models have seen frequent use in the discovery and optimization of novel molecules with affinity to a target, the clarification of absorption, distribution, metabolism, excretion and toxicity properties as well as physicochemical characterization. The aim of this review is to illustrate some of the in silico methods for pharmacology that are used in drug discovery. Further applications of these methods to specific targets and their limitations will be discussed in the second accompanying part of this review. British Journal of Pharmacology (2007) 152, 9–20; doi:10.1038/sj.bjp.0707305
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Docking and scoring in virtual screening for drug discovery: methods and applications
Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1549 · Cited by 4,150
Handbook of Molecular Descriptors
Todeschini, R., & Consonni, V. (2000) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527613106 · Cited by 4,107 · cited 1×
“The number and type of molecular descriptors is large and varied (Karelson, 2000; Todeschini and Consonni, 2000) and thus procedures to select those that are most relevant for modelling the biological effect of interest are extremely important (Walters and Goldman, 2005).”
BackgroundCramer, R. D., Patterson, D. E., & Bunce, J. D. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00226a005 · Cited by 3,931
p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure
Hansch, C., & Fujita, T. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a035 · Cited by 2,313 · cited 2×
“Such papers paved the way for the recognition of lipophilicity and electronic properties as major determinants of PD and PK responses, as best illustrated by the epoch-making and still ongoing work of Corwin Hansch (Hansch and Fujita, 1964; Hansch, 1972), a founding father of drug design.”
BackgroundWolber, G., & Langer, T. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049885e · Cited by 1,954
Willett, P., Barnard, J. M., & Downs, G. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9800211 · Cited by 1,765
Virtual screening of chemical libraries
Shoichet, B. K. (2004) · Nature · doi:10.1038/nature03197 · Cited by 1,425
Concepts and applications of molecular similarity
Johnson, M. A., & Maggiora, G. M. (1990) · Wiley eBooks · Cited by 1,301
ModBase, a database of annotated comparative protein structure models, and associated resources
Pieper, U., Webb, B. M., Barkan, D. T., Schneidman-Duhovny, D., Schlessinger, A., Braberg, H., Yang, Z., Meng, E. C., Pettersen, E. F., Huang, C. C., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1091 · Cited by 1,071
Hit and lead generation: beyond high-throughput screening
Bleicher, K. H., Böhm, H.-J., Müller, K., & Alanine, A. I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1086 · Cited by 1,056
Meyer, H. (1899) · Archiv für Experimentelle Pathologie und Pharmakologie · doi:10.1007/bf01834479 · Cited by 1,014
Integration of virtual and high-throughput screening
Bajorath, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd941 · Cited by 930
Gohlke, H., & Klebe, G. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020802)41:15<2644::aid-anie2644>3.0.co;2-o · Cited by 843
Global mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811
The efficiency of multi-target drugs: the network approach might help drug design
CSERMELY, P., AGOSTON, V, & PONGOR, S. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.02.007 · Cited by 803
“Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening
Schneider, G., Neidhart, W., Giller, T., & Schmid, G. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991004)38:19<2894::aid-anie2894>3.0.co;2-f · Cited by 717
Charifson, P. S., Corkery, J. J., Murcko, M. A., & Walters, W. P. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990352k · Cited by 698
Molecular descriptors in QSAR/QSPR
Karelson, M. M. (2000) · Cited by 698
Pharmacophore perception, development, and use in drug design
Güner, O. F. (2000) · Medical Entomology and Zoology · Cited by 689
Virtual ligand screening: strategies, perspectives and limitations
Klebe, G. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.05.012 · Cited by 664
Prediction of Protein−Ligand Interactions. Docking and Scoring: Successes and Gaps
Leach, A. R., Shoichet, B. K., & Peishoff, C. E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060999m · Cited by 646
Pastor, M., Cruciani, G., McLay, I., Pickett, S., & Clementi, S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000941m · Cited by 467
Computational Methods in Developing Quantitative Structure-Activity Relationships (QSAR): A Review
Dudek, A., Arodz, T., & Galvez, J. (2006) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620706776055539 · Cited by 429
TarFisDock: a web server for identifying drug targets with docking approach
Li, H., Gao, Z., Kang, L., Zhang, H., Yang, K., Yu, K., Luo, X., Zhu, W., Chen, K., Shen, J., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl114 · Cited by 420
Martin, Y. C., Bures, M. G., Danaher, E. A., DeLazzer, J., Lico, I., & Pavlik, P. A. (1993) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00141577 · Cited by 406
3D QSAR in Drug Design: Ligand-Protein Interactions and Molecular Similarity
(1998) · Springer eBooks · doi:10.1007/0-306-46857-3 · Cited by 379
In silico pharmacology for drug discovery: applications to targets and beyond
Ekins, S., Mestres, J., & Testa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707306 · Cited by 365
Self-citationChen, Y. Z., & Zhi, D. G. (2001) · Proteins: Structure, Function, and Genetics · doi:10.1002/1097-0134(20010501)43:2<217::aid-prot1032>3.0.co;2-g · Cited by 353
Nidhi, Glick, M., Davies, J. W., & Jenkins, J. L. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060003g · Cited by 340
Identification of Common Functional Configurations Among Molecules
Barnum, D., Greene, J., Smellie, A., & Sprague, P. (1996) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci950273r · Cited by 319
Bissantz, C., Bernard, P., Hibert, M., & Rognan, D. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10237 · Cited by 293
A Stepwise Approach for Defining the Applicability Domain of SAR and QSAR Models
Dimitrov, S., Dimitrova, G., Pavlov, T., Dimitrova, N., Patlewicz, G., Niemela, J., & Mekenyan, O. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci0500381 · Cited by 291
Quantitative structure-activity relationship methods: Perspectives on drug discovery and toxicology
Perkins, R., Fang, H., Tong, W., & Welsh, W. J. (2003) · Environmental Toxicology and Chemistry · doi:10.1897/01-171 · Cited by 286
Prediction of Drug Binding Affinities by Comparative Binding Energy Analysis
Ortiz, A. R., Pisabarro, M. T., Gago, F., & Wade, R. C. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00014a020 · Cited by 266
Computational methods for the structural alignment of molecules
Lemmen, C., & Lengauer, T. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008194019144 · Cited by 262
Hert, J., Willett, P., Wilton, D. J., Acklin, P., Azzaoui, K., Jacoby, E., & Schuffenhauer, A. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b409865j · Cited by 260
Developing a Dynamic Pharmacophore Model for HIV-1 Integrase
Carlson, H. A., Masukawa, K. M., Rubins, K., Bushman, F. D., Jorgensen, W. L., Lins, R. D., Briggs, J. M., & McCammon, J. A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990322h · Cited by 259
Poroikov, V. V., Filimonov, D. A., Borodina, Y. V., Lagunin, A. A., & Kos, A. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000383k · Cited by 254
MODBASE: a database of annotated comparative protein structure models and associated resources
Pieper, U. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj059 · Cited by 253
Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins
Schuffenhauer, A., Floersheim, P., Acklin, P., & Jacoby, E. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci025569t · Cited by 252
Integrating virtual screening in lead discovery
Oprea, T. I., & Matter, H. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.06.008 · Cited by 250
Structure-based virtual screening of chemical libraries for drug discovery
Ghosh, S., Nie, A., An, J., & Huang, Z. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.04.002 · Cited by 246
Xue, L., & Bajorath, J. (2000) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207003331454 · Cited by 241
Evers, A., & Klabunde, T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0491804 · Cited by 234
3-D Pharmacophores in Drug Discovery
Mason, J., Good, A., & Martin, E. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397843 · Cited by 232
3D database searching in drug design
Martin, Y. C. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00090a001 · Cited by 226
Chem-Bioinformatics: Comparative QSAR at the Interface between Chemistry and Biology
Hansch, C., Hoekman, D., Leo, A., Weininger, D., & Selassie, C. D. (2002) · Chemical Reviews · doi:10.1021/cr0102009 · Cited by 218
Finding New Tricks For Old Drugs: An Efficient Route For Public-Sector Drug Discovery
O'Connor, K. A., & Roth, B. L. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1900 · Cited by 215
Comparison of Automated Docking Programs as Virtual Screening Tools
Cummings, M. D., DesJarlais, R. L., Gibbs, A. C., Mohan, V., & Jaeger, E. P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049798d · Cited by 207
sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank
Kellenberger, E., Muller, P., Schalon, C., Bret, G., Foata, N., & Rognan, D. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050372x · Cited by 201
Application of Topological Descriptors in QSAR and Drug Design: History and New Trends
Gozalbes, R., Doucet, J., & Derouin, F. (2002) · Current Drug Target -Infectious Disorders · doi:10.2174/1568005024605909 · Cited by 184
Evers, A., Hessler, G., Matter, H., & Klabunde, T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050090o · Cited by 183
Zhang, Q., & Muegge, I. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050468i · Cited by 182
Ligand-Based Structural Hypotheses for Virtual Screening
Jain, A. N. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030520f · Cited by 181
Pharmacophores and Pharmacophore Searches
(2006) · Methods and Principles in Medicinal Chemistry · doi:10.1002/3527609164 · Cited by 181
EKINS, S., NIKOLSKY, Y., & NIKOLSKAYA, T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.02.006 · Cited by 180
Self-citationNuclear Hormone Receptor Targeted Virtual Screening
Schapira, M., Abagyan, R., & Totrov, M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0300173 · Cited by 180
Flohr, S., Kurz, M., Kostenis, E., Brkovich, A., Fournier, A., & Klabunde, T. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0111043 · Cited by 178
Novel technologies for virtual screening
Lengauer, T., Lemmen, C., Rarey, M., & Zimmermann, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)02939-3 · Cited by 168
HIV-1 Integrase Pharmacophore: Discovery of Inhibitors through Three-Dimensional Database Searching
Nicklaus, M. C., Neamati, N., Hong, H., Mazumder, A., Sunder, S., Chen, J., Milne, G. W. A., & Pommier, Y. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960596u · Cited by 162
Evers, A., & Klebe, G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0311487 · Cited by 161
Lahana, R. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01393-8 · Cited by 160
Current State and Perspectives of 3D-QSAR
Akamatsu, M. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023392887 · Cited by 151
Chen, Y., & Ung, C. Y. (2001) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(01)00109-7 · Cited by 146
Testa, B., & Krämer, S. D. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790169 · Cited by 139
Self-citationComputer systems for the prediction of xenobiotic metabolism
Langowski, J., & Long, A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00011-x · Cited by 138
Virtual Screening Methods that Complement HTS
Stahura, F. L., & Bajorath, J. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207043328706 · Cited by 131
Albert, A. (1985) · Springer eBooks · doi:10.1007/978-94-009-4846-4 · Cited by 125
Similarity-based approaches to virtual screening
Willett, P. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310603 · Cited by 124
Automated chemical hypothesis generation and database searching with Catalyst®
Sprague, P. W. (1995) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02174464 · Cited by 123
Comparative Molecular Similarity Indices Analysis: CoMSIA
Klebe, G. (1998) · Springer eBooks · doi:10.1007/0-306-46858-1_6 · Cited by 119
Glossary of Terms Used in Medicinal Chemistry
Wermuth, C. G., Ganellin, C. R., Lindberg, P., et al. (2016) · IUPAC Standards Online · doi:10.1515/iupac.70.0050 · Cited by 118
Parallel Screening: A Novel Concept in Pharmacophore Modeling and Virtual Screening
Steindl, T. M., Schuster, D., Laggner, C., et al. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci6002043 · Cited by 111
Quantitative Relationships Between Lipophilic Character and Drug Metabolism
Hansch, C. H. (1972) · Drug Metabolism Reviews · doi:10.3109/03602537208993906 · Cited by 110
Recovering the true targets of specific ligands by virtual screening of the protein data bank
Paul, N., Kellenberger, E., Bret, G., Müller, P., & Rognan, D. (2004) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10625 · Cited by 109
The Biochemistry of Drug Metabolism – An Introduction
Testa, B., & Krämer, S. D. (2006) · Chemistry & Biodiversity · doi:10.1002/cbdv.200690111 · Cited by 104
Self-citationFrom large networks to small molecules
Sharom, J. R., Bellows, D. S., & Tyers, M. (2003) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2003.12.007 · Cited by 103
HierS: Hierarchical Scaffold Clustering Using Topological Chemical Graphs
Wilkens, S. J., Janes, J. O., & Su, A. I. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049032d · Cited by 101
Ligand-supported homology modelling of protein binding-sites using knowledge-based potentials.
Evers, A., Gohlke, H., & Klebe, G. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.032 · Cited by 101
Towards a new age of virtual ADME/TOX and multidimensional drug discovery
Ekins, S., Boulanger, B., Swaan, P. W., & Hupcey, M. A. Z. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1020816005910 · Cited by 101
Self-citationMultiple Active Site Corrections for Docking and Virtual Screening
Vigers, G. P. A., & Rizzi, J. P. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030161o · Cited by 98
The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
Mannens, G., Snel, C., Hendrickx, J., Verhaeghe, T., Jeune, L. L., Bode, W., van Beijsterveldt, L., Lavrijsen, K., Leempoels, J., Osselaer, N. V., et al. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.553 · Cited by 98
SHED: Shannon Entropy Descriptors from Topological Feature Distributions
Gregori‐Puigjané, E., & Mestres, J. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci0600509 · Cited by 98
Self-citationSchuffenhauer, A., Zimmermann, J., Stoop, R., van der Vyver, J.-J., Lecchini, S., & Jacoby, E. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010385k · Cited by 94
Ligand-Based Approach to In Silico Pharmacology: Nuclear Receptor Profiling
Mestres, J., Martín‐Couce, L., Gregori‐Puigjané, E., Cases, M., & Boyer, S. K. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600300k · Cited by 94
Self-citationFliri, A. F. J., Loging, W., Thadeio, P. F., & Volkmann, R. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050494g · Cited by 91
Polański, J., Bąk, A., Gieleciak, R. M., & Magdziarz, T. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050314b · Cited by 90
Conformational changes and drug action.
Burgen, A. S. (1981) · PubMed · Cited by 90
Koide, Y., Hasegawa, T., Takahashi, A., Endo, A., Mochizuki, N., Nakagawa, M., & Nishida, A. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020080c · Cited by 86
Comparative molecular similarity indices analysis: CoMSIA
Klebe, G. (1998) · Perspectives in Drug Discovery and Design · doi:10.1023/a:1017025803403 · Cited by 82
An approach toward the problem of outliers in QSAR
Verma, R. P., & Hansch, C. H. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.002 · Cited by 80
Combinatorial computational method gives new picomolar ligands for a known enzyme
Grzybowski, B. A., Ishchenko, A. V., Kim, C., Topalov, G. T., Chapman, R., Christianson, D. W., Whitesides, G. M., & Shakhnovich, E. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032673399 · Cited by 80
Hartley, D. P., Dai, X., He, Y. D., Carlini, E. J., Wang, B., Huskey, S.-E. W., Ulrich, R. G., Rushmore, T. H., Evers, R., & Evans, D. C. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1159 · Cited by 80
Predicting Drug Metabolism - An Evaluation of the Expert SystemMETEOR
Testa, B., Balmat, A.-L., Long, A., & Judson, P. N. (2005) · Chemistry & Biodiversity · doi:10.1002/cbdv.200590064 · Cited by 78
Self-citationChemical substructures in drug discovery
Merlot, C., Domine, D., Cleva, C., & Church, D. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02740-5 · Cited by 78
Development of biologically active compounds by combining 3D QSAR and structure-based design methods
Sippl, W. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1023888813526 · Cited by 74
Using Absolute and Relative Reasoning in the Prediction of the Potential Metabolism of Xenobiotics
Button, W. G., Judson, P. N., Long, A., & Vessey, J. D. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0202739 · Cited by 73
What is the relevance of bioinformatics to pharmacology?
Whittaker, P. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00197-4 · Cited by 68
Stiefl, N., & Baumann, K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021077w · Cited by 68
Systems-ADME/Tox: Resources and network approaches
Ekins, S. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.05.005 · Cited by 66
Self-citationVirtual Screening for Kinase Targets
Muegge, I., & Enyedy, I. J. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455684 · Cited by 65
Data Visualization during the Early Stages of Drug Discovery
Maniyar, D. M., Nabney, I. T., Williams, B. S., & Sewing, A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050471a · Cited by 61
Guided Docking Approaches to Structure-Based Design and Screening
Fradera, X., & Mestres, J. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043451104 · Cited by 60
Self-citationDesign, docking, and evaluation of multiple libraries against multiple targets
Lamb, M. L., Burdick, K. W., Toba, S., Young, M. M., Skillman, A. G., Zou, X., Arnold, J. R., & Kuntz, I. D. (2001) · Proteins Structure Function and Bioinformatics · doi:10.1002/1097-0134(20010215)42:3<296::aid-prot20>3.0.co;2-f · Cited by 58
The Delphic Boat: What Genomes Tell Us
Danchin, A. (2002) · DigitalGeorgetown (Georgetown University Library) · Cited by 52
Computation of the physio‐chemical properties and data mining of large molecular collections
Cheng, A., Diller, D., Dixon, S. L., Egan, W. J., Lauri, G., & Merz, K. M. (2001) · Journal of Computational Chemistry · doi:10.1002/jcc.1164 · Cited by 50
Implementation of an ADME enabling selection and visualization tool for drug discovery
Stoner, C. L., Gifford, E., Stankovic, C. J., Lepsy, C. S., Brodfuehrer, J., Prasad, J. V. N. V., & Surendran, N. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20020 · Cited by 50
Comprehensive Computational Assessment of ADME Properties Using Mapping Techniques
Balakin, K. V., Ivanenkov, Y. A., Savchuk, N., Ivashchenko, A. A., & Ekins, S. (2005) · Current Drug Discovery Technologies · doi:10.2174/1570163054064666 · Cited by 50
Self-citationIn Silico Simulation of Inhibitor Drug Effects on Nuclear Factor-κB Pathway Dynamics
Sung, M., & Simon, R. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.70 · Cited by 49
Rapid Computational Identification of the Targets of Protein Kinase Inhibitors
Rockey, W. M., & Elcock, A. H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049461b · Cited by 49
The Delphic boat: What genomes tell us
Mai, L. (2003) · American Journal of Human Biology · doi:10.1002/ajhb.10207 · Cited by 47
Quantitative Structure Activity Relationships in Drug Metabolism
Chohan, K. K., Paine, S. W., & Waters, N. J. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606778108960 · Cited by 46
A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM
Ekins, S., Kirillov, E., Rakhmatulin, E. A., & Nikolskaya, T. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002717 · Cited by 45
Self-citationReceptors: from fiction to fact
Ariëns, E. J. (1979) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(79)90005-1 · Cited by 43
Identification of “Latent Hits” in Compound Screening Collections
Mestres, J., & Veeneman, G. H. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034078c · Cited by 43
Self-citationLearning from the Data: Mining of Large High-Throughput Screening Databases
Yan, S. F., King, F. J., He, Y., Caldwell, J. S., & Zhou, Y. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060102u · Cited by 43
Computational neuropharmacology: dynamical approaches in drug discovery
Aradi, I., & Érdi, P. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.03.004 · Cited by 41
Reengineering the pharmaceutical industry by crash-testing molecules
Swaan, P. W., & Ekins, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03557-9 · Cited by 39
Self-citationMestres, J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03593-2 · Cited by 32
Self-citationApplication of data mining approaches to drug delivery
Ekins, S., Shimada, J., & Chang, C. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.005 · Cited by 31
Self-citationC-QSAR: a database of 18,000 QSARs and associated biological and physical data
Kurup, A. (2003) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1025322008290 · Cited by 28
Annotating and mining the ligand-target chemogenomics knowledge space
Schuffenhauer, A., & Jacoby, E. (2004) · Drug Discovery Today BIOSILICO · doi:10.1016/s1741-8364(04)02408-4 · Cited by 27
Feature selection in quantitative structure-activity relationships.
Walters, W. P., & Goldman, B. B. (2005) · PubMed · Cited by 23
FCP: functional coverage of the proteome by structures
García-Serna, R., Opatowski, L., & Mestres, J. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl188 · Cited by 15
Self-citationArQiologist: An Integrated Decision Support Tool for Lead Optimization
Rojnuckarin, A., Gschwend, D. A., Rotstein, S. H., & Hartsough, D. S. (2004) · Journal of Chemical Information and Modeling · doi:10.1021/ci049880h · Cited by 15
InfVis− Platform-Independent Visual Data Mining of Multidimensional Chemical Data Sets
Oellien, F., Ihlenfeldt, W., & Gasteiger, J. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050202k · Cited by 14
Cited by
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Network Pharmacology Approach for Medicinal Plants: Review and Assessment
Noor, F., Tahir ul Qamar, M., Ashfaq, U. A., Albutti, A., Alwashmi, A. S. S., & Aljasir, M. A. (2022) · Pharmaceuticals · doi:10.3390/ph15050572 · Cited by 540
Exploiting drug-disease relationships for computational drug repositioning
Dudley, J. T., Deshpande, T., & Butte, A. J. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr013 · Cited by 524
The Toxicity Data Landscape for Environmental Chemicals
Judson, R., Richard, A., Dix, D. J., Houck, K., Martin, M., Kavlock, R., Dellarco, V., Henry, T., Holderman, T., Sayre, P., et al. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0800168 · Cited by 508
Predicting drug metabolism: experiment and/or computation?
Kirchmair, J., Göller, A. H., Lang, D., Kunze, J., Testa, B., Wilson, I. D., Glen, R. C., & Schneider, G. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4581 · Cited by 502
Self-citation
Metadata
- Authors
- Ekins, S., Mestres, J., & Testa, B.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-09
- Volume
- 152
- Issue
- 1
- Pages
- 9-20
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2024311391
- Cited by
- 703
- References
- 128
- FWCI
- 25.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.